Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical research to translate promising therapeutic concepts into meaningful patient impact.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
Investigator Awards - Neuroendocrine Tumor Research Foundation support researchers pursuing basic, translational, and select clinical studies to advance neuroendocrine cancer detection and treatment.